Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 Apr 1999

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to Lung Cancer Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 10096969
DOI: 10.1016/s0022-5223(99)70294-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markersPMID 10096969Read ↗

Molecular prognostication of non-small cell lung cancer.Semantic proximity Read ↗

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.Semantic proximity Read ↗

The Value of Biomarkers in Patients With Sarcomatoid Carcinoma of the Lung: Molecular Analysis of 33 CasesSemantic proximity Read ↗

Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patternsSemantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 MutationsSemantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on <i>EGFR</i> , <i>KRAS</i> , and <i>TP53</i> MutationsSemantic proximity Read ↗

2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant ClassificationSemantic proximity Read ↗

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.Semantic proximity Read ↗

Pharmacogenetic and Germline Prognostic Markers of Lung CancerSemantic proximity Read ↗

The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database.Semantic proximity Read ↗

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma PrognosisSemantic proximity Read ↗

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.